Sign In
Buy PHCUF
$6.63
+0 (+0%)
At Close: Jun 22, 2026
Photocure ASA (PHCUF) M&A Call Transcript
01:42pm, Friday, 05'th Jun 2026
Photocure ASA (PHCUF) M&A Call Transcript
Photocure ASA to Acquire Vesica Health Inc., Strengthening Leadership in Bladder Cancer Diagnostics
11:46am, Thursday, 04'th Jun 2026
OSLO, Norway, June 4, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO), a leader in bladder cancer diagnostics, today announced the signing and successful completion of its acquisition of Vesica Health,
Photocure ASA (PHCUF) Q1 2026 Earnings Call Transcript
02:31pm, Thursday, 07'th May 2026
Photocure ASA (PHCUF) Q1 2026 Earnings Call Transcript
Photocure ASA: Results for the first quarter of 2026
02:13am, Thursday, 07'th May 2026
OSLO, Norway, May 7, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO) today reported Hexvix ® /Cysview ® revenues of NOK 139.0 million in the first quarter of 2026 (Q1 2025: NOK 125.3 million), and an
Photocure ASA: Update on Regulatory Classification for OAY Equipment
03:30am, Monday, 13'th Apr 2026
OSLO, Norway, April 13, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO) today announced that the U.S. Food and Drug Administration (FDA) has communicated to Photocure that it plans to issue a proposed o
Photocure ASA (PHCUF) Q4 2025 Earnings Call Transcript
01:45pm, Wednesday, 18'th Feb 2026
Photocure ASA (PHCUF) Q4 2025 Earnings Call Transcript
Photocure ASA: Results for the fourth quarter of 2025
01:40am, Wednesday, 18'th Feb 2026
OSLO, Norway, Feb. 18, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO) today reported Hexvix ® /Cysview ® revenues of NOK 135.1 million in the fourth quarter of 2025 (Q4 2024: NOK 128.6 million), a
Photocure ASA (PHCUF) Q3 2025 Earnings Call Transcript
02:36pm, Wednesday, 29'th Oct 2025
Photocure ASA (OTCPK:PHCUF) Q3 2025 Earnings Call October 29, 2025 9:00 AM EDT Company Participants Daniel Schneider - President & CEO Erik Dahl - Chief Financial Officer Presentation Daniel Schneider
Photocure ASA: Results for the third quarter of 2025
02:21am, Wednesday, 29'th Oct 2025
OSLO, Norway , Oct. 29, 2025 /PRNewswire/ -- Photocure ASA (OSE: PHO) today reported Hexvix ® /Cysview ® revenues of NOK 134.1 million in the third quarter of 2025 (Q3 2024: NOK 120.1 million), and
Photocure ASA: Results for the second quarter of 2025
01:09am, Wednesday, 30'th Jul 2025
OSLO, Norway , July 30, 2025 /PRNewswire/ -- Photocure ASA (OSE: PHO) today reported Hexvix ® /Cysview ® revenues of NOK 135.6 million in the second quarter of 2025 (Q2 2024: NOK 122.4 million), a
Photocure ASA: Results for the first quarter of 2025
01:07am, Thursday, 08'th May 2025
OSLO, Norway , May 8, 2025 /PRNewswire/ -- Photocure ASA (OSE: PHO) today reported Hexvix ® /Cysview ® revenues of NOK 125.3 million in the first quarter of 2025 (Q1 2024: NOK 116.8 million), and
Photocure ASA: Results for the fourth quarter of 2024
02:26am, Wednesday, 19'th Feb 2025
OSLO, Norway , Feb. 19, 2025 /PRNewswire/ -- Photocure ASA (OSE:PHO) today reported Hexvix®/Cysview® revenues of NOK 128.6 million in the fourth quarter of 2024 (Q4 2023: NOK 114.2 million) and EBI
Photocure ASA: Results for the third quarter of 2024
02:45am, Wednesday, 13'th Nov 2024
OSLO, Norway , Nov. 13, 2024 /PRNewswire/ -- Photocure ASA (OSE: PHO) today reported Hexvix®/Cysview® revenues of NOK 120.1 million in the third quarter of 2024 (Q3 2023: NOK 107.3 million), and
